These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23328831)

  • 61. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Dizbay M; Tunccan OG; Sezer BE; Hizel K
    Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.
    Hsu JF; Chu SM; Lien R; Chiu CH; Chiang MC; Fu RH; Lee CW; Huang HR; Tsai MH
    Am J Infect Control; 2014 Jan; 42(1):23-7. PubMed ID: 24176602
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An Intrinsic Strain of Colistin-resistant Acinetobacter Isolated from a Japanese Patient.
    Takizawa E; Yamada K; Oinuma K; Sato K; Niki M; Namikawa H; Fujimoto H; Asai K; Kaneko Y; Kakeya H
    Intern Med; 2016; 55(16):2301-6. PubMed ID: 27523013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia.
    Chuang YC; Chang SC; Wang WK
    Crit Care Med; 2012 Aug; 40(8):2273-80. PubMed ID: 22809902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
    Tiwari V; Kapil A; Moganty RR
    Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Dahdouh E; Hajjar M; Suarez M; Daoud Z
    Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276
    [No Abstract]   [Full Text] [Related]  

  • 69. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
    Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K
    J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
    Apisarnthanarak A; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
    [No Abstract]   [Full Text] [Related]  

  • 73. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
    Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
    Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Using the rate of bacterial clearance determined by real-time polymerase chain reaction to evaluate antibiotic effectiveness in Acinetobacter baumannii bacteremia.
    Decker BK; Powers JH
    Crit Care Med; 2013 May; 41(5):e47. PubMed ID: 23591227
    [No Abstract]   [Full Text] [Related]  

  • 75. The authors reply.
    Chuang YC; Chang SC; Wang WK
    Crit Care Med; 2013 May; 41(5):e47-8. PubMed ID: 23591228
    [No Abstract]   [Full Text] [Related]  

  • 76. Immediate incubation of blood cultures is critical to bring about better bacteremia outcomes.
    Bignardi GE; Berrington A; Koerner R; Settle C
    J Infect; 2015 May; 70(5):546. PubMed ID: 25530468
    [No Abstract]   [Full Text] [Related]  

  • 77. Bacteremia caused by Acinetobacter ursingii.
    Loubinoux J; Mihaila-Amrouche L; Le Fleche A; Pigne E; Huchon G; Grimont PA; Bouvet A
    J Clin Microbiol; 2003 Mar; 41(3):1337-8. PubMed ID: 12624081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of Acinetobacter baumannii strains expressing the Type 6 secretion system in patients with bacteremia.
    Repizo GD
    Virulence; 2017 Oct; 8(7):1099-1101. PubMed ID: 28650701
    [No Abstract]   [Full Text] [Related]  

  • 79. Acinetobacter in the air: did Maryland get it wrong?
    Munoz-Price LS
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):833-4. PubMed ID: 26081997
    [No Abstract]   [Full Text] [Related]  

  • 80. Acinetobacter baumannii Hallux Infection Secondary to Partial Amputation in a US Soldier A Case Report.
    Glover MP; Beaman LA; Berry-Cabán CS
    J Am Podiatr Med Assoc; 2015 Nov; 105(6):560-3. PubMed ID: 26667510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.